ARTICLE | Company News
Sepracor, MedPointe Inc. sales and marketing update
May 10, 2004 7:00 AM UTC
The companies amended their 2002 deal under which SEPR is co-promoting MedPointe's Astelin azelastine nasal spray to treat allergic rhinitis in the U.S. As amended, SEPR will provide only sample cove...